Mahalagang Update

CollPlant Secures European Patent for rhCollagen-Based Aesthetic and Reconstructive Products

CollPlant Biotechnologies announced it has secured a European patent allowance for its rhCollagen-based injectable fillers and regenerative ...

Nagbabagang Balita

Jerusalem, 8 June, 2025 (TPS-IL) — CollPlant Biotechnologies announced it has secured a European patent allowance for its rhCollagen-based injectable fillers and regenerative breast implants. The patent, valid through 2041, strengthens the Israeli startup’s position in the $6.3 billion soft tissue filler and $3 billion breast implant markets.

The company’s technology uses non-animal-derived recombinant human collagen to develop 3D biocompatible, degradable implants aimed at natural tissue regeneration. CEO Yehiel Tal called the patent a key milestone in expanding CollPlant’s reach in Europe, a strategic target market for the company’s regenerative medicine solutions.

Live na Pagsabog na Mga Update

Nagbabagang Balita Saklaw

Real-time na saklaw ng mga pagsabog na balita mula sa Israel at sa Gitnang Silangan. Manatiling updated sa pinakabagong mga kaganapan habang nangyayari ang mga ito.

Huwebes, 11 Hunyo 2026 Patuloy na na-update
home front 7 mga oras nakaraan Bago

Matapos ang pagtatasa sa sitwasyon, nananatiling hindi nagbabago ang polisiya sa pagtatanggol ng Home Front Command at mananatili itong epektibo hanggang Linggo, Hunyo 14, 2026, alas-8 ng gabi.

Patakaran ng Home Front Command sa pagtatanggol, hindi magbabago hanggang Hunyo 14, 2026, 8:00 PM, matapos ang pagsusuri sa sitwasyon ng IDF.